Elena Dobryn
About Elena Dobryn
Elena Dobryn is a Research Associate I at Jnana Therapeutics, where she has worked since 2021. She holds a Bachelor of Science in Bioengineering and Biomedical Engineering from Northeastern University and has previous experience in various research roles at Merck, LogicBio Therapeutics, and The Karp Lab.
Work at Jnana Therapeutics
Elena Dobryn has been employed at Jnana Therapeutics as a Research Associate I since 2021. In this role, she contributes to research initiatives aimed at developing innovative therapies. Her position focuses on advancing the understanding of biological processes and supporting projects that align with the company's mission to improve patient outcomes. Dobryn's work environment emphasizes learning and knowledge sharing, which aligns with her professional motivations.
Previous Experience in Biotechnology
Before joining Jnana Therapeutics, Elena Dobryn gained valuable experience through various co-op positions in the biotechnology sector. In 2020, she worked as an Experimental Biology Co-op at Merck for five months. Prior to that, she served as a Research Co-op at The Karp Lab in 2018, also for five months, located in the Greater Boston Area. Additionally, she worked at LogicBio Therapeutics as a Vector Production Co-op in 2019 for five months in Cambridge, MA. These roles provided her with a solid foundation in experimental biology and research methodologies.
Education and Expertise
Elena Dobryn earned her Bachelor of Science in Bioengineering and Biomedical Engineering from Northeastern University, completing her studies from 2016 to 2021. This educational background equipped her with essential knowledge and skills in engineering principles as applied to biological systems. Her academic training supports her current research efforts and informs her contributions to the field of biotechnology.
Motivation and Professional Focus
Elena Dobryn is motivated by a work environment that prioritizes learning and the exchange of knowledge. She finds significance in her work when it contributes to helping patients, reflecting a commitment to improving healthcare outcomes. This focus drives her research efforts and aligns with her career goals in the biotechnology industry.